{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T18:30:20Z","timestamp":1720722620185},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1016\/j.ijantimicag.2004.03.001","type":"journal-article","created":{"date-parts":[[2004,8,26]],"date-time":"2004-08-26T22:13:35Z","timestamp":1093558415000},"page":"35-38","source":"Crossref","is-referenced-by-count":14,"special_numbering":"S1","title":["Newer carbapenems for urinary tract infections"],"prefix":"10.1016","volume":"24","author":[{"given":"Tetsuro","family":"Matsumoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuro","family":"Muratani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl D","key":"10.1016\/j.ijantimicag.2004.03.001_BIB1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/12.suppl_D.1","article-title":"Thienamycin: development of imipenem-cilastatin","volume":"12","author":"Kahan","year":"1983","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2004.03.001_BIB2","first-page":"241","article-title":"Overview of a new carbapenem, panipenem\/betamipron","volume":"20","author":"Shimada","year":"1994","journal-title":"Drugs Exp Clin Res"},{"key":"10.1016\/j.ijantimicag.2004.03.001_BIB3","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1128\/AAC.34.6.994","article-title":"In vitro activity of LJC10627, a new carbapenem antibiotic with high stability to dehydropeptidase I","volume":"34","author":"Ubukata","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2004.03.001_BIB4","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.2165\/00003495-200262150-00005","article-title":"Biapenem","volume":"62","author":"Perry","year":"2002","journal-title":"Drugs"},{"key":"10.1016\/j.ijantimicag.2004.03.001_BIB5","doi-asserted-by":"crossref","first-page":"519","DOI":"10.7164\/antibiotics.43.519","article-title":"A novel carbapenem antibiotic, SM-7338 structure-activity relationships","volume":"43","author":"Sunagawa","year":"1990","journal-title":"J Antibiot"},{"key":"10.1016\/j.ijantimicag.2004.03.001_BIB6","unstructured":"National Committee for Clinical Laboratory Standards: M7-A5. Methods for dilution: antimicrobial susceptibility tests for bacteria that grow aerobically approved standard. 5th ed., M-100-S11. Wayne, PA: National Committee for Clinical Laboratory Standards; 2000."},{"key":"10.1016\/j.ijantimicag.2004.03.001_BIB7","unstructured":"Kumazawa J, Matsumoto T. Epidemiology of microbial resistance today. In: Naber KG, Pechere JC, Kumazawa J, Khoury S, Gerberding JL, Schaffer AJ, editors. Nosocomial and Health Care Associated Infections in Urology. 1st ed. UK: Plymbridge Distributors Ltd.; 2001. p. 61\u20136."},{"key":"10.1016\/j.ijantimicag.2004.03.001_BIB8","first-page":"254","article-title":"Phase III comparative clinical trial of panipenem\/betamipron (PAPM\/BP) with imipenem\/cilastatin sodium (IPM\/CS) for the treatment of complicated urinary tract infections","volume":"54","author":"Kumazawa","year":"1992","journal-title":"Nishinihon J Urol"},{"key":"10.1016\/j.ijantimicag.2004.03.001_BIB9","first-page":"954","article-title":"Clinical study of meropenem for complicated urinary tract infection\u2014double blind comparative study comparing to imipenem\/cilastatin","volume":"54","author":"Kumazawa","year":"1992","journal-title":"Nishinihon J Urol"},{"key":"10.1016\/j.ijantimicag.2004.03.001_BIB10","first-page":"218","article-title":"Comparative study of biapenem and imipenem\/cilastatin for complicated urinary tract infection","volume":"48","author":"Kawada","year":"2000","journal-title":"Chemotherapy"},{"key":"10.1016\/j.ijantimicag.2004.03.001_BIB11","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1086\/375594","article-title":"Clinical and bacteriological characteristics of IMP-type metallo-beta-lactamase-producing Pseudomonas aeruginosa","volume":"37","author":"Hirakata","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2004.03.001_BIB12","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1128\/AAC.45.2.480-484.2001","article-title":"Carbapenem resistance mechanisms in Pseudomonas aeruginosa clinical isolates","volume":"45","author":"Pai","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2004.03.001_BIB13","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/jac\/42.4.427","article-title":"In-vitro and in-vivo antibacterial activities of CS^834, a new oral carbapenem","volume":"42","author":"Sakagawa","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2004.03.001_BIB14","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1128\/AAC.45.1.203-207.2001","article-title":"In vitro and in vivo antibacterial activities of L-084, a novel oral carbapenem, against causative organisms of respiratory tract infections","volume":"45","author":"Miyazaki","year":"2001","journal-title":"Antimicrob Agents Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857904000925?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857904000925?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T10:51:04Z","timestamp":1549277464000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857904000925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":14,"alternative-id":["S0924857904000925"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2004.03.001","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}